课题基金 / 基金详情

A prospective, randomised, double-blind trial of extended- versus bolus-infusion ?-lactam therapy in infective exacerbations of cystic fibrosis

A prospective, randomised, double-blind trial of extended- versus bolus-infusion ?-lactam therapy in infective exacerbations of cystic fibrosis
一项前瞻性、随机、双盲试验,比较延长输注 β-内酰胺疗法与推注 β-内酰胺疗法治疗囊性纤维化感染性加重的情况
批准号:
nhmrc : 1039914
负责人:
Dr Katherine Langan
金额:
$9.9万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Postgraduate Scholarships
财政年份:
2012
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2012-01-01 至 2016-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
我是一名传染病医生,专注于使用抗生素治疗感染的最有效方法。囊性纤维化患者经常发生肺部感染,导致这种感染的细菌铜绿假单胞菌可能很难治疗。我将研究在治疗囊性纤维化患者的铜绿假单胞菌肺部感染时,长期输注抗生素是否比标准治疗更有效。
英文摘要
I am an infectious diseases physician focused on the most effective way to use antibiotics to treat infections. People with cystic fibrosis often get lung infections and the bacteria that causes this, Pseudomonas aeruginosa, can be difficult to treat. I will be investigating whether infusing antibiotics over a prolonged period of time is more effective than standard therapy in treatment of Pseudomonas aeruginosa lung infections in patients with cystic fibrosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金